BioSpace News Archive

Revance to Host Investor Day on September 19, 2023

Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced that the company will host an Investor Day on September 19, 2023, from 9:30 AM ET to 1:00 PM ET.

August 22, 2023
·
1 min read
Biotech Bay

Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer

Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer.

August 22, 2023
·
5 min read
Drug Development

SELLAS Life Sciences Independent Data Monitoring Committee Recommends Galinpepimut-S REGAL Trial to Continue Without any Modifications

SELLAS Life Sciences Group, Inc. today announced a positive review of the ongoing Phase 3 REGAL clinical trial of galinpepimut-S (GPS) in acute myeloid leukemia (AML) by the Independent Data Monitoring Committee (IDMC).

August 22, 2023
·
4 min read
Biotech Beach

Thermo Fisher Scientific Introduces New Chromosomal Microarray with Two-Day Turnaround Time to Increase Lab Productivity

Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time.

August 22, 2023
·
3 min read
Deals

Grander Closes Acquisition of PolarityTE, Inc. Assets

Grander Acquisition LLC, an entity led by Michael Brauser, announced the Company has closed on its acquisition of substantially all of the assets of RegenETP, Inc., a biotechnology company that had been developing regenerative tissue products.

August 22, 2023
·
2 min read
Asieris Pharmaceuticals Unveils 2023 Semi-Annual Report, Demonstrating Initial Success of Specialty Pharma Strategy and Multi-Product Synergistic Commercialization

Asieris Pharmaceuticals released its 2023 Semi-Annual Report that highlights the accelerated progress in clinical trials, aiming to address the field’s highly unmet diagnostic and therapeutic needs.

August 22, 2023
·
9 min read
Biotech Beach

Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution

Endonovo Therapeutics, Inc. announced its inclusion on the Federal Supply Schedule for SofPulse® Pulsed Electro Magnetic Field medical devices for distribution throughout the Federal healthcare supply channels.

August 22, 2023
·
6 min read
Deals

Paradigm Therapeutics Acquires Late Stage “Breakthrough Therapy” Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)

Paradigm Therapeutics Inc., a biopharmaceutical company, today announced the completion of the acquisition of the worldwide rights of SD-101, a topical whole-body treatment for all subtypes of Epidermolysis Bullosa (EB), from Amicus Therapeutics.

August 22, 2023
·
3 min read
Business

Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 – Conference Call to Follow

Kane Biotech Inc. will announce its second quarter 2023 financial results after market close on Tuesday, August 29, 2023.

August 22, 2023
·
3 min read
Pharm Country

Acurx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 11-13, 2023

Acurx Pharmaceuticals, Inc. announced today that David P. Luci , President & CEO, will present at the H.C. Wainwright 25th Annual Global Investment Conference.

August 22, 2023
·
2 min read